Fig. 6From: RETRACTED ARTICLE: Mesenchymal stem cell-derived exosomal miR-146a reverses diabetic β-cell dedifferentiationMiR-146a-knockdown bmMSC-derived exosomes fail to reverse β-cell dedifferentiation in vivo. a Blood glucose in control + PBS, T2DM + PBS, T2DM + bmMDEmiR-NC KD, and T2DM + bmMDEmiR-146a KD rats. b–e IPGTT and IPITT were performed after the last intervention of bmMDEsmiR-NC KD and bmMDEsmiR-146a KD. Values of the areas under the curve in IPGTT and IPITT were measured. f Fasting serum insulin of control + PBS, T2DM + PBS, T2DM + bmMDEmiR-NC KD, and T2DM + bmMDEmiR-146a KD rats as indicated. g Paraffin-embedded sections from the indicated groups were immunolabeled for insulin along with PDX1, FOXO1, NGN3, and OCT4 (scale bar 20 μm). h–k RT-qPCR analyses for Pdx1, Foxo1, Ngn3, and Oct4 in islets from the above groups. Data are presented as the mean ± SEM (∗P < 0.05; ∗∗P < 0.01; ***P < 0.001)Back to article page